Compare Archer Aviation Inc (ACHR) vs Davita Inc (DVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Archer Aviation Inc vs Davita Inc — how do they compare? Archer Aviation Inc trades at $6.81 (market cap $4.78B), while Davita Inc trades at $178.34 (market cap $11.72B). The key difference: Davita Inc is far larger — about 2.5× Archer Aviation Inc's market cap, and Davita Inc is trading nearer its 52-week high, Archer Aviation Inc nearer its low. Which is the better fit depends on your goals.
| ACHR | DVA | |
|---|---|---|
Market Cap | $4.78B | $11.72B |
Sector | Industrials | Health |
52-Week High | $13.64 | $240.96 |
52-Week Low | $4.44 | $103.87 |
Enterprise Value | $3.12B | $24.44B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Archer Aviation (ACHR) trades at $5.59, up 6.88% today, with a bullish technical signal from moving averages. The company reported a Q2 2026 loss of $0.34 per share, missing estimates, but revenue trends show growth from $300,000 in 2025 to $2 million in 2026. Recent news highlights a transformative deal with Boeing to acquire Wisk Aero, Insitu, and SkyGrid, expanding into autonomous aviation and defense, which spurred a stock surge and high options trading activity.
The outlook is optimistic due to strategic expansion and strong analyst support, with 78% buy ratings and a 78.7% upside price target. However, risks include persistent losses, negative cash flow from operations, and execution challenges in scaling new businesses, requiring careful monitoring of profitability milestones.
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Archer Aviation Inc
Archer Aviation develops electric vertical takeoff and landing (eVTOL) aircraft for urban air mobility. Its flagship, Midnight aircraft, is designed for air taxi services, aiming to transform urban travel with sustainable aviation.
Read more on ACHR →About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →
